News About: Goverment
KFDA under fire for operational errors in website
The Korea Food and Drug Administration is drawing fire for a series of malfunctioning glitches in its website.
One of the reported weaknesses in KFDA website program (easydrug) involved deletion of drug-related fil...
DUR system to cover non-reimbursable medicines
The Health Insurance Review and Assessment Service (HIRAS) says that from December, the current Drug Utilization Review (DUR) will be applicable to medicines which have not been covered by the national health insuranc...
KFDA to ease product license system
The Korea Food and Drug Administration is considering granting the market authorization of locally commissioned drugs.
In a drug related session on November 16, KFDA official Hong Soon-wook said that the administra...
Government urged to publicize new DMF system
Starting next January, the Korea Food and Drug Administration has unveiled its plan to implement a new DMF (Drug Master File) system, under which it is necessary for drug manufacturers (or importers) to gain a prior a...
Antibiotics and colds
The Korea Food and Drug Administration said in a recently published leaflet that adults believe if they are sick enough to see a doctor for a cold, they should get antibiotic treatment.
The leaflet also said these ...
Number of ADHD patients more than doubled
The number of recorded patients suffering from ADHD (attention deficit hyperactivity disorder) exceeded 640,000 as of the end of 2009.
The National Health Insurance Corporation (NHIC) said that the number of ADHD p...
DUR of OTC products ruled out
The government said it will not introduce the Drug Utilization Review (DUR) system for over-the-counter (OTC) medicines from this December.
The Ministry of Health & Welfare confirmed on November 10 that the full-fl...
2011 NMC budget raises debate
The budget of the National Medical Center (NMC) for next year should be modified due to decreasing trend of patients in the third quarter of this year, according to a lawmaker.
The Ministry Health and Welfare propo...
KFDA to lift restriction of joint bioequivalence testing
From November next year, drug makers will be able to make joint (commissioned) bioequivalence testing without any restriction, according to the Korea Food and Drug Administration.
“We decided to follow the suggesti...
Health insurance to cover Kogenate FS
The National Health Insurance will cover Bayer’s Kogenate FS, a recombinant factor VIII product, from November 10, according to the Ministry of Health and Welfare.
The insurance price of Kogenate FS is 511 won per ...
